FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

385053008: Prolonged-release oral capsule (dose form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3565132012 Prolonged-release oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3565133019 Prolonged-release oral capsule (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3861471000005113 depotkapsel da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)
4838781000005119 depotkapsler da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


5 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release oral capsule Is a A solid single-dose form that is a shell made of gelatin or other substances. The contents of the shell may be a solid, semi-solid or liquid. false Inferred relationship Some
Prolonged-release oral capsule Is a Oral capsule false Inferred relationship Some
Prolonged-release oral capsule Is a Modified-release oral capsule true Inferred relationship Some
Prolonged-release oral capsule Has dose form administration method (attribute) A method of administration of a dose form by taking into the mouth and allowing to pass down the throat. true Inferred relationship Some
Prolonged-release oral capsule Dose form intended site describes the general anatomic location that the dose form has been formulated for administration to or at. The intended site is not intended to describe a precise site or route of administration. For example, eye drops (prepared for ocular intended site) are subject to pharmacopoeial standards for pH, and sterility. An intended site for a dose form that is for administration by swallowing. true Inferred relationship Some
Prolonged-release oral capsule Has dose form release characteristic (attribute) A release characteristic where a dose form displays a slower release of the active substance(s) than that of a conventional-release dose form. This may be achieved by a special formulation design, manufacturing process or other methods. true Inferred relationship Some
Prolonged-release oral capsule Has basic dose form (attribute) A solid single-dose form that is a shell made of gelatin or other substances. The contents of the shell may be a solid, semi-solid or liquid. true Inferred relationship Some
Prolonged-release oral capsule Has dose form transformation (attribute) No transformation true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely carvedilol phosphate 10 milligram/1 each prolonged-release oral capsule (clinical drug) Has manufactured dose form True Prolonged-release oral capsule Inferred relationship Some
Product containing precisely carvedilol phosphate 20 milligram/1 each prolonged-release oral capsule (clinical drug) Has manufactured dose form True Prolonged-release oral capsule Inferred relationship Some
Product containing precisely carvedilol phosphate 40 milligram/1 each prolonged-release oral capsule (clinical drug) Has manufactured dose form True Prolonged-release oral capsule Inferred relationship Some
Carvedilol phosphate 80 mg prolonged-release oral capsule Has manufactured dose form True Prolonged-release oral capsule Inferred relationship Some
Cyclobenzaprine hydrochloride 15 mg prolonged-release oral capsule Has manufactured dose form True Prolonged-release oral capsule Inferred relationship Some
Cyclobenzaprine hydrochloride 30 mg prolonged-release oral capsule Has manufactured dose form True Prolonged-release oral capsule Inferred relationship Some
Prolonged-release oral hard capsule (dose form) Is a True Prolonged-release oral capsule Inferred relationship Some
Baclofen 10 mg prolonged-release oral capsule Has manufactured dose form True Prolonged-release oral capsule Inferred relationship Some
Product containing precisely minocycline (as minocycline hydrochloride) 100 milligram/1 each prolonged-release oral capsule (clinical drug) Has manufactured dose form True Prolonged-release oral capsule Inferred relationship Some
Methylphenidate hydrochloride 5 mg prolonged-release oral capsule Has manufactured dose form True Prolonged-release oral capsule Inferred relationship Some
Propiverine hydrochloride 30 mg prolonged-release oral capsule Has manufactured dose form True Prolonged-release oral capsule Inferred relationship Some
Product containing precisely propiverine hydrochloride 45 milligram/1 each prolonged-release oral capsule (clinical drug) Has manufactured dose form True Prolonged-release oral capsule Inferred relationship Some
Product containing precisely sodium valproate 150 milligram/1 each prolonged-release oral capsule (clinical drug) Has manufactured dose form True Prolonged-release oral capsule Inferred relationship Some
Product containing precisely sodium valproate 300 milligram/1 each prolonged-release oral capsule (clinical drug) Has manufactured dose form True Prolonged-release oral capsule Inferred relationship Some
Prolonged-release capsule, hard Is a True Prolonged-release oral capsule Inferred relationship Some

Start Previous Page 3 of 3


This concept is not in any reference sets

Back to Start